Lv1
30 积分 2023-12-10 加入
Letter to the Editor – Final Survival Results from the Penelope-B trial investigating palbociclib vs placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy – PENELOPE-B
6小时前
求助中
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial
21天前
已完结
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
1个月前
已完结
Epidemiology of early vs. Late recurrence among women with Early-Stage estrogen Receptor-Positive breast cancer in the pathways study
1年前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
1年前
已完结
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
1年前
已完结
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
1年前
已完结
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
1年前
已完结
Global Stage Distribution of Breast Cancer at Diagnosis
1年前
已完结
The potential of ctDNA analysis in breast cancer
1年前
已完结
Effectiveness and safety of remimazolam combined with alfentanil in hysteroscopic examination: A prospective, randomized, single-blind trial
皖公网安备34019202002308
